EMPOWERING MYELOMA ADVOCACY ACROSS EUROPE


LinkedIn facebook twitter youtube
News archive

 

 

Myeloma Patients Europe (MPE) will hold a webinar to review the most recent updates on the approved COVID-19 vaccines in Europe and how they affect myeloma and AL amyloidosis patients.

 

The talk will be given by Dr Anna Sureda, Head of Hematology Department, Institut Català d’Oncología (ICO), Spain.

 

This webinar will take place on Thursday 29 April 2021  (17:00-18:00 PM CET). The session will last about 60 minutes, including a 40-minute presentation from Dr Sureda, followed by a 20-minute Q&A session.

 

Registration is free of charge. We encourage you to share the registration link with colleagues and members of the patient community who might be interested in attending the webinar.

 

Should you be unable to attend the webinar, please feel free to send your questions in advance to our Communications Manager, Ana Vallejo, at vallejo@mpeurope.org and we will make sure they reach our speaker.

 

 

A recording of the webinar will be available shortly after the session.

 

We look forward to your participation!







Recent news

» CAR-T cell therapy in myeloma

» Daratumumab subcutaneous, first approved treatment for newly diagnosed AL amyloidosis in Europe

Leave a Reply

Your email address will not be published. Required fields are marked *

I accept the Privacy Policy * for Click to select the duration you give consent until.